A detailed history of Hantz Financial Services, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 907 shares of DXCM stock, worth $72,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares
907
Previous 22,117 95.9%
Holding current value
$72,777
Previous $2.51 Million 97.57%
% of portfolio
0.0%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $1.36 Million - $2.46 Million
-21,210 Reduced 95.9%
907 $61,000
Q2 2024

Jul 30, 2024

BUY
$110.31 - $140.45 $2.44 Million - $3.11 Million
22,117 New
22,117 $2.51 Million
Q1 2024

Aug 06, 2024

BUY
$114.22 - $140.1 $16,219 - $19,894
142 Added 0.66%
21,511 $2.98 Million
Q4 2023

Aug 06, 2024

BUY
$75.49 - $124.16 $259,912 - $427,482
3,443 Added 19.21%
21,369 $2.65 Million
Q3 2023

Aug 06, 2024

BUY
$86.06 - $137.93 $38,985 - $62,482
453 Added 2.59%
17,926 $1.67 Million
Q2 2023

Aug 06, 2024

BUY
$112.47 - $130.98 $31,041 - $36,150
276 Added 1.6%
17,473 $2.25 Million
Q1 2023

Aug 06, 2024

BUY
$104.0 - $122.92 $42,224 - $49,905
406 Added 2.42%
17,197 $2 Million
Q4 2022

Aug 06, 2024

BUY
$84.98 - $122.67 $84,300 - $121,688
992 Added 6.28%
16,791 $1.9 Million
Q3 2022

Aug 06, 2024

BUY
$76.35 - $94.18 $41,992 - $51,799
550 Added 3.61%
15,799 $1.27 Million
Q2 2022

Aug 06, 2024

BUY
$67.99 - $132.89 $833,761 - $1.63 Million
12,263 Added 410.68%
15,249 $1.14 Million
Q1 2022

Aug 06, 2024

BUY
$94.08 - $130.2 $48,168 - $66,662
512 Added 20.7%
2,986 $1.53 Million
Q4 2021

Aug 06, 2024

BUY
$129.87 - $162.82 $27,922 - $35,006
215 Added 9.52%
2,474 $1.33 Million
Q3 2021

Aug 06, 2024

BUY
$106.71 - $143.18 $57,089 - $76,601
535 Added 31.03%
2,259 $1.24 Million
Q2 2021

Aug 06, 2024

SELL
$80.99 - $107.93 $1.65 Million - $2.2 Million
-20,393 Reduced 92.21%
1,724 $736,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.